tiprankstipranks
Trending News
More News >
OnKure Therapeutics (OKUR)
NASDAQ:OKUR
US Market
Advertisement

OnKure Therapeutics (OKUR) Stock Statistics & Valuation Metrics

Compare
333 Followers

Total Valuation

OnKure Therapeutics has a market cap or net worth of $37.21M. The enterprise value is -$50.26M.
Market Cap$37.21M
Enterprise Value-$50.26M

Share Statistics

OnKure Therapeutics has 12,843,434 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,843,434
Owned by Insiders8.71%
Owned by Institutions0.03%

Financial Efficiency

OnKure Therapeutics’s return on equity (ROE) is -0.51 and return on invested capital (ROIC) is -51.58%.
Return on Equity (ROE)-0.51
Return on Assets (ROA)-0.46
Return on Invested Capital (ROIC)-51.58%
Return on Capital Employed (ROCE)-0.52
Revenue Per Employee0.00
Profits Per Employee-1.15M
Employee Count46
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of OnKure Therapeutics is ―. OnKure Therapeutics’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value1.10
Price to FCF
Price to Operating Cash Flow-5.88
PEG Ratio

Income Statement

In the last 12 months, OnKure Therapeutics had revenue of 0.00 and earned -52.67M in profits. Earnings per share was -3.95.
Revenue0.00
Gross Profit0.00
Operating Income-54.39M
Pretax Income-52.67M
Net Income-52.67M
EBITDA-51.71M
Earnings Per Share (EPS)-3.95

Cash Flow

In the last 12 months, operating cash flow was -61.29M and capital expenditures -64.00K, giving a free cash flow of -61.36M billion.
Operating Cash Flow-61.29M
Free Cash Flow-61.36M
Free Cash Flow per Share-4.78

Dividends & Yields

OnKure Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.49
52-Week Price Change-80.77%
50-Day Moving Average2.46
200-Day Moving Average4.99
Relative Strength Index (RSI)57.67
Average Volume (3m)103.98K

Important Dates

OnKure Therapeutics upcoming earnings date is Aug 12, 2025, Before Open (Confirmed).
Last Earnings DateMay 6, 2025
Next Earnings DateAug 12, 2025
Ex-Dividend Date

Financial Position

OnKure Therapeutics as a current ratio of 10.73, with Debt / Equity ratio of 1.05%
Current Ratio10.73
Quick Ratio10.73
Debt to Market Cap<0.01
Net Debt to EBITDA2.12
Interest Coverage Ratio-181.29

Taxes

In the past 12 months, OnKure Therapeutics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

OnKure Therapeutics EV to EBITDA ratio is -0.10, with an EV/FCF ratio of -0.10.
EV to Sales0.00
EV to EBITDA-0.10
EV to Free Cash Flow-0.10
EV to Operating Cash Flow-0.10

Balance Sheet

OnKure Therapeutics has $83.37M in cash and marketable securities with $823.00K in debt, giving a net cash position of -$82.55M billion.
Cash & Marketable Securities$83.37M
Total Debt$823.00K
Net Cash-$82.55M
Net Cash Per Share-$6.43
Tangible Book Value Per Share$7.78

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for OnKure Therapeutics is $30.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$30.00
Price Target Upside990.91% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast
EPS Growth Forecast68.13%

Scores

Smart Score3
AI Score42
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis